Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Powell

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Pharmaceutical Research|May 1, 1998
Stability of alkoxycarbonylamidine prodrugsZ Shahrokh, E Lee, A G Olivero, et al.
AIDS Research and Human Retroviruses|February 1, 1995
Effect of adjuvants on immunogenicity of MN recombinant glycoprotein 120 in guinea pigsM F Powell, D J Eastman, A Lim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993
HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactionsA Sette, J Sidney, C Oseroff, et al.
AIDS Research and Human Retroviruses|January 1, 1994
Immunogenicity and HIV-1 virus neutralization of MN recombinant glycoprotein 120/HIV-1 QS21 vaccine in baboons M F Powell, J L Cleland, D J Eastman, et al.
Journal of Pharmaceutical Sciences|April 3, 1999
Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing responseJ L Cleland, A Lim, A Daugherty, et al.
The Journal of Infectious Diseases|January 1, 1996
Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1P W Berman, K K Murthy, T Wrin, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Pharmaceutical Research|May 1, 1998
Stability of alkoxycarbonylamidine prodrugsZ Shahrokh, E Lee, A G Olivero, et al.
AIDS Research and Human Retroviruses|February 1, 1995
Effect of adjuvants on immunogenicity of MN recombinant glycoprotein 120 in guinea pigsM F Powell, D J Eastman, A Lim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993
HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactionsA Sette, J Sidney, C Oseroff, et al.
AIDS Research and Human Retroviruses|January 1, 1994
Immunogenicity and HIV-1 virus neutralization of MN recombinant glycoprotein 120/HIV-1 QS21 vaccine in baboons M F Powell, J L Cleland, D J Eastman, et al.
Journal of Pharmaceutical Sciences|April 3, 1999
Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing responseJ L Cleland, A Lim, A Daugherty, et al.
The Journal of Infectious Diseases|January 1, 1996
Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1P W Berman, K K Murthy, T Wrin, et al.
Pageof 6